212 related articles for article (PubMed ID: 25894544)
41. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
[TBL] [Abstract][Full Text] [Related]
42. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A
Oncogene; 2005 May; 24(21):3427-35. PubMed ID: 15735694
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of
Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
[TBL] [Abstract][Full Text] [Related]
44. T3 receptors in human pituitary tumors.
Machiavelli GA; Pauni M; Heredia Sereno GM; Szijan I; Basso A; Burdman JA
Neurol Res; 2009 Nov; 31(9):928-30. PubMed ID: 19138463
[TBL] [Abstract][Full Text] [Related]
45. HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
De Martino M; Esposito F; Pellecchia S; Cortez Cardoso Penha R; Botti G; Fusco A; Chieffi P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344629
[TBL] [Abstract][Full Text] [Related]
46. Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.
Piekielko-Witkowska A; Kedzierska H; Poplawski P; Wojcicka A; Rybicka B; Maksymowicz M; Grajkowska W; Matyja E; Mandat T; Bonicki W; Nauman P
Biochim Biophys Acta; 2013 Jun; 1832(6):763-72. PubMed ID: 23462647
[TBL] [Abstract][Full Text] [Related]
47. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
48. Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.
Otsuka F; Tamiya T; Yamauchi T; Ogura T; Ohmoto T; Makino H
Regul Pept; 1999 Aug; 83(1):31-8. PubMed ID: 10498342
[TBL] [Abstract][Full Text] [Related]
49. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251.
Fan H; Guo H; Zhang IY; Liu B; Luan L; Xu S; Hou X; Liu W; Zhang R; Wang X; Pang Q
Brain Res; 2011 Apr; 1384():9-14. PubMed ID: 21300033
[TBL] [Abstract][Full Text] [Related]
50. Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion.
Shorts-Cary L; Xu M; Ertel J; Kleinschmidt-Demasters BK; Lillehei K; Matsuoka I; Nielsen-Preiss S; Wierman ME
Endocrinology; 2007 Mar; 148(3):967-75. PubMed ID: 17138656
[TBL] [Abstract][Full Text] [Related]
51. Critical role of the HMGA2 gene in pituitary adenomas.
Fedele M; Pierantoni GM; Visone R; Fusco A
Cell Cycle; 2006 Sep; 5(18):2045-8. PubMed ID: 16969098
[TBL] [Abstract][Full Text] [Related]
52. Expression of neurotensin and its receptors in pituitary adenomas.
Giorgi RR; Chile T; Bello AR; Reyes R; Fortes MA; Machado MC; Cescato VA; Musolino NR; Bronstein MD; Giannella-Neto D; Corrêa-Giannella ML
J Neuroendocrinol; 2008 Sep; 20(9):1052-7. PubMed ID: 18624930
[TBL] [Abstract][Full Text] [Related]
53. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
Alexander JM; Swearingen B; Tindall GT; Klibanski A
J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
[TBL] [Abstract][Full Text] [Related]
54. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
Du Q; Hu B; Feng Y; Wang Z; Wang X; Zhu D; Zhu Y; Jiang X; Wang H
J Clin Endocrinol Metab; 2019 Jun; 104(6):2419-2434. PubMed ID: 30721952
[TBL] [Abstract][Full Text] [Related]
55. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
[TBL] [Abstract][Full Text] [Related]
56. Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.
Wu Y; Bai J; Li Z; Wang F; Cao L; Liu C; Yu S; Yu G; Zhang Y
Pituitary; 2015 Jun; 18(3):335-42. PubMed ID: 24917361
[TBL] [Abstract][Full Text] [Related]
57. Mir-23b and miR-130b expression is downregulated in pituitary adenomas.
Leone V; Langella C; D'Angelo D; Mussnich P; Wierinckx A; Terracciano L; Raverot G; Lachuer J; Rotondi S; Jaffrain-Rea ML; Trouillas J; Fusco A
Mol Cell Endocrinol; 2014 Jun; 390(1-2):1-7. PubMed ID: 24681352
[TBL] [Abstract][Full Text] [Related]
58. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
59. Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.
Zhang X; Sun H; Danila DC; Johnson SR; Zhou Y; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 2002 Mar; 87(3):1262-7. PubMed ID: 11889197
[TBL] [Abstract][Full Text] [Related]
60. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
